The effect of acute carbon monoxide (CO) breathing on blood oxygenation and tumour hypoxia was related to the radiation response of the C3H/Tif mammary carcinoma. Blood gas analysis showed that CO breathing caused a time-and dose-dependent formation of carboxyhaemoglobin (HbCO), a significant left shift of the oxygen dissociation curve and a reduction in tumour blood perfusion. These factors all contributed to a marked drop in tumour oxygen supply. In agreement with this, tumour hypoxia was found to be significantly increased: Microelectrode P02 measurements showed a clear relationship between CO concentration and the proportion of low Po2 measurements (< 5 mmHg). The fraction of clonogenic hypoxic cells increased from 8% in air-breathing animals to 13%, 18% and 54% with 75,220 and 660 p.p.m. CO respectively. The tumour hypoxia resulted in significant radiation modification. The local tumour control after single-dose and fractionated irradiation gave TCD50 enhancement ratios (relative to air-breathing controls) of 0.90, 0.85 and 0.89 for single dose and five or ten fractions given in 5 days (P<0.005 for all values). For 15 fractions in 5 days with 6-6-and 12 h intervals, the TCD50 was similar in CO-and air-breathing mice, presumably as a consequence of insufficient reoxygenation during the short inter-fraction intervals. It is concluded that elevated HbCO levels lead to increased tumour hypoxia and that the induced hypoxia has a significant impact on the local tumour control also after fractionated irradiation.
The presence of hypoxic cells in solid tumours is well documented (Moulder & Rockwell, 1984; Gatenby et al., 1988; Overgaard, 1989; Vaupel et al., 1991; Horsman, 1993; Okunieff et al., 1993) , and tumour hypoxia is believed to be a major cause of clinical radioresistance in head and neck cancer and certain other cancer types (Dische, 1989; Overgaard, 1989; . The amount of oxygen available for a given tissue depends on both the blood flow and the blood oxygenation (Hirst, 1986) . The latter parameter is potentially influenced by several factors: inspired air characteristics (smoke/pollution), cardiopulmonary status, haemoglobin (Hb) amount and 'quality' and Hb-oxygen affinity (Overgaard, 1988) . Apart from the registration of Hb level, details about these parameters are usually not available in clinical radiotherapy studies. A study including 115 head and neck cancer patients has recently shown that the total Hb concentration is a very crude indicator of the amount of oxygen available for tissues. Instead the concept of 'oxygen unloading capacity' has been introduced as a potentially more reliable prognostic factor (Overgaard, 1988; Overgaard et al., 1992) .
Tumour oxygenation is theoretically influenced by the presence of carboxyhemoglobin (HbCO), which is formed when CO binds to Hb. Even low concentrations of CO can lead to a significant level of HbCO in the blood, as the affinity of Hb for CO is about 230 times that for oxygen (Roughton & Darling, 1944) . The major source of CO in the inspired air is cigarette smoke (Nordenberg et al., 1990) . Many patients treated with radiotherapy, especially those with head and neck cancer, are cigarette smokers (Des Rochers et al., 1992; Overgaard et al., 1992) , and they have been found to have HbCO levels as high as 18% compared with 1-2% in non-smokers (Bunn & Forget, 1986; Nordenberg et al., 1990; Overgaard et al., 1992) . Previous animal studies have suggested that increased HbCO may reduce the tumour response to single-dose irradiation (Siemann et al., 1978; Grau et al., 1992) . The aim of the present experiments was to study the relationship between blood/tumour oxygenation and tumour radiation response during CO breathing. Blood oxygenation was evaluated from blood gas analysis (HbCO, Hb, P5m), tumour perfusion from 86RbCl experiments, and the effect on tumour oxygenation was measured directly by P02 microelectrode and indirectly by radiobiological hypoxic fraction estimation.
Material and methods

Mice and tumours
The C3H mouse mammary carcinoma was grown in the feet of 10-to 14-week-old CDFI/Bom (C3H/tif Y x DBA/2 c) male mice. The derivation and maintenance of the tumour system has been described in detail previously (Overgaard, 1980; Grau & Overgaard, 1988 Blood sampling Venous blood samples (100-150 pl) were collected from the suborbital sinus and analysed for HbCO%, pH, P02, Pco2, oxygen saturation and total Hb% on an Acid Base Laboratory ABL300 (Radiometer, Copenhagen) connected to an OSM3 haemoximeter (Radiometer, Copenhagen) calibrated for mouse blood. The Pso was calculated automatically from these values (Siggaard-Andersen et al., 1988) . This value is defined as the oxygen partial pressure at which Hb is 50% saturated with oxygen at normal pH, and it thus describes the position of the Hb-oxygen dissociation curve. A fraction of the blood samples was analysed for the content of 2,3-diphosphoglycerate (2,3-DPG). This was done by a commercial kit (Sigma, St Louis, MO, USA). In brief, the breakdown of 2,3-DPG to glyceraldehyde 3-phosphate requires simultaneous formation of NAD, which can be quantitated spectrophotometrically. The test was done on protein-free supernatant, and the values calculated either as whole-blood concentration (mmolI 1) or as a percentage of the haemoglobin content, the latter parameter calculated by dividing the whole-blood 2,3-DPG by the Hb content.
Intratumoral P02 measurement The intratumoral oxygen tension was measured using a fine-needle polarographic electrode (Eppendorf, Hamburg, Germany), as described previously . In brief, P02 measurements were conducted with mice restrained in lucite jigs with the tumour-bearing foot exposed and loosely taped in such a way that the normal blood supply was not impaired. The needle was inserted up to a depth of 1 mm into the tumour, and automatically moved through the tumour in forward steps of 0.7 mm followed by a rapid retraction of 0.3 mm. Three to six electrode tracks were used in each tumour, yielding a total of 45-90 measurements per tumour. The relative frequency of the Po2 was automatically calculated and displayed as a histogram. For the present purpose, the data were expressed as the percentage of measurements with a P02 value less than or equal to 5 mmHg.
Tumour blood perfusion measurement Tumour blood perfusion was measured by the 86RbCl extraction technique (Sapirstein, 1958) . The practical application of this technique in our set-up has been described in detail previously (Horsman et al., 1989; Grau et al., 1992) . Briefly, a volume of 0.1 ml of 86RbCl was injected intravenously into each mouse. After 2 min the mice were sacrificed and the tumour-bearing leg was clamped. Tumours were excised for counting immediately after sacrifice. Determinations of radioactivity were made on a gamma-counter, and the radioactive counts were expressed as percentage injected per g of tumour.
Irradiation Local irradiation was given with 250-kV X-rays (2.3 Gy min-', 3.1 mm Cu HVL, 10 mA) to mice with the tumour-bearing foot immersed in a water bath (25°C) to secure homogeneous dose distribution. Fractionated irradiation was given with an interval between multiple daily fractions of 6 h, and an overall treatment time of 4-4+ days. Animals receiving X-rays under hypoxic conditions had the tumour-bearing leg clamped 5 min before and during the period of irradiation. Clamping was achieved by constriction of the blood flow using a rubber tube tightened around the leg .
End-points and statistics
Local tumour control assay The effect of graded doses of radiation was evaluated as the dose required to produce local tumour control in 50% of the treated animals (TCD50). Tumour control was defined as complete absence of macroscopic relapse within 90 days. Each single experiment included 6-9 dose points each with 6-12 mice. Less than 5% of the animals were censored as a result of death, amputation or distant metastases. Data were analysed by logit analysis (Grau & Overgaard, 1988) . The enhancement ratio (ER) was calculated as the ratio of TCD50 values obtained under normal air-breathing and CO-breathing conditions. An ER significantly lower than 1 thus reflected radiation protection.
Hypoxic fraction The proportion of radiobiologically hypoxic cells (HF) was estimated from the tumour control data obtained for mice breathing CO at 0, 75, 220, or 660 p.p.m. together with data for the clamped tumours. Onestep direct estimation was performed using a modification of the 'cxpest' computer program, with fixed a-and P-values of 0.53 Gy-1 and 0.087 Gy 2 respectively (Bentzen & Grau, 1991) .
Statistical methods The experimental data were calculated as means and 95% confidence limits using normal distribution unless otherwise stated in the text. Student's t-test with a significance level of 5% was used in all analyses. Univariate linear regression analysis (SPSS/PC + V4.01) was used to test for correlation. The estimation of HF from tumour control data and its confidence intervals were calculated from the 'cpest' computer program, as described by Bentzen & Grau (1991) .
Results
Breathing rate Figure 1 shows the ventilation rate in CO-and air-breathing mice. The initial breathing rate was about 270 min-', but when the mice became accustomed to the chamber this value dropped to about 200 min-'. There was no difference between air-and CO-breathing animals. This HbCO level at 90min was 25%. In the tumour experiments a pretreatment breathing time Figure 7b , and listed in Table I . The HF increased from 8% in air-breathing animals to 13% (75 p.p.m.), 18% (220 p.p.m.) and 54% (660 p.p.m.). The correlation was highly significant (r2 = 0.97, P <0.05).
The correlation between HbCO and HF was significant (r2 = 0.97, P< 0.05) and similar to that observed for the P02.
45-60 min prior to 86RbCl injection. There was a significant correlation between the HbCO level and the decrease in tumour perfusion (r2=0.98, P<0.001). The reductions in blood perfusion were 12% (NS), 45% (P<0.05) and 82% (P<0.01) for average HbCO levels of 13%, 25% and 51% respectively.
The combined effects of changes in effective Hb and tumour blood perfusion on the oxygen supply to tumours are illustrated in Figure 6 . All values are expressed as percentage of the values obtained in air-breathing controls. The perfusion effects are represented with the regression line from Figure 5 . The combined effect was calculated as the product of the reduction in effective Hb and the estimated perfusion reduction for animals at the actual HbCO level for each mouse. It is seen that the negative impact of perfusion is considerably greater than the reduction in effective Hb. When combined, the amount of oxygen supplied to the tumour is decreased down to 15% of the control value for the highest HbCO level. Within the clinically relevant range, the reduction is about 30-40%. for all schedules, Figure 9 shows the local tumour control as a function of the total radiation dose. For comparison, the responses of clamped tumours are indicated with dashed lines. There was a small, but highly significant increase in TCD50 when the radiation was given in one, five or ten fractions. This effect could not be found for 15 fractions, in which case the two dose-response curves overlapped. The calculated TCD5o and the corresponding enhancement ratios are listed in Table I . For one, five and ten fractions, the radiation ERs were 0.90, 0.85 and 0.89 respectively, which was highly significant (P <0.005 for all values). Finally, chronic smoking was simulated in a single experiment. Mice maintained from tumour implantation until the end of the five-fraction radiation treatment -a period of about 21 days -in a 110 p.p.m. CO environment (HbCO 10-14%) had a TCD50 that was not significantly different from that observed Clamp for mice that were only acutely exposed to 220 p.p.m. CO during treatment (Figure 9, bottom left) . The TCD50 was significantly higher than for air-breathing controls (P<0.05). The Hb levels of these chronic breathers were identical to those of untreated controls (data not shown).
Discussion
This study has demonstrated that CO breathing causes a significant decrease in tumour oxygen supply, which in turn leads to severe tumour hypoxia and a reduction in radiation response. It is established that the tumour oxygen supply is impaired by three factors: reduction in effective Hb from HbCO formation, decrease in P50 and reduction in tumour blood perfusion. The combined effect results in at least 30-40% reduction in oxygen supply to the tumour within the clinical HbCO range, and up to 85% for high CO concentrations.
Our data show a dose-dependent reduction in P50 down to about 50% of the normal value. Such increase in blood oxygen affinity will decrease the oxygen utilisation depending on the tissue P02 ). It is not yet possible to quantify exactly these changes in mouse blood in the same way as has been done in humans . However, an impression of the relative magnitude of the Haldane effect can be obtained if the tissue Po2 is kept constant. Then the effect of a reduction in P50 would be of the same magnitude as the perfusion effect, i.e. up to 80% reduction at the highest HbCO. A reliable estimate of the tumour P02 can be obtained from the microelectrode measurements. In the present experiments the mean P02 decreased linearly from 14 mmHg (air) to 3 mmHg (CO 660 p.p.m.). Such a drop with increasing tumour hypoxia will facilitate oxygen release because of the increased concentration gradient, and thereby to some extent counteract the P"o effect.
A reduction in P50 has also been observed for several therapeutic agents. These agents include the substituted benzaldehyde BW12C, which preferentially binds to oxyhaemoglobin and thereby increases the affinity of Hb for oxygen (Beddell et al., 1984; . Several experimental studies have shown a significant increase in tumour hypoxia and a reduction in radiation response when mice are treated with BW12C (Adams et al., 1986; Adams, 1989; Honess et al., 1989) . However, recent studies have suggested that the observed radiation modification may be more related to BW12C-induced blood flow reductions than to the change in P50 (Honess et al., 1991 . A similar property was observed for CO breathing, when perfusion reductions up to 80% were seen at the highest CO concentration. Previous studies from our laboratory with the C3H mouse mammary carcinoma and the vasoactive agent hydralazine showed that at least a 50% decrease in perfusion is required to see any effect on radiation response and full radiobiological hypoxia is only seen after a 90% reduction in perfusion (Horsman et al., 1989) . The Hb affinity for oxygen can also be decreased in order to improve tumour radiosensitivity. This has been shown experimentally with antilipidaemic agents and a combination of inosine, puruvate and phosphate (2,3-DPG precursors) (Siemann et al., 1989) . It is not known to what extent blood perfusion changes are involved in the mechanisms of action of these agents.
2,3-DPG is one of the most important allosteric factors controlling the position of the oxygen dissociation curve (Bunn & Forget, 1986) . In conditions characterised by hypoxia (chronic lung disease, cardiac insufficiency, anaemia), the level of 2,3-DPG is increased, thereby making the oxygenated Hb more readily available to the tissues by an increase in the P50. This effect could not be seen in the present study. A possible reason is that the hypoxic stimulus from HbCO is not sufficient to trigger a sufficient biochemical response.
The chronic effects of smoking have generally been believed to include a compensatory polycythaemia. However, the magnitude of such polycythaemia in persons without chronic lung disease is very small. In a large study of more than 4000 persons the Hb level in smokers was less than 3% above that of non-smokers (Nordenberg et al., 1990) , and in head and neck cancer patients no increase in Hb as a function of HbCO level has been found . In the present mouse material we found no increase in Hb during the 3 weeks of chronic 'incubation' at 10% HbCO. So it is unlikely that chronic CO breathing/smoking leads to any significant adaptation, which is also shown by the data in Figure 9 . The present set-up with acute CO breathing therefore seems to be a reasonable simulation of the clinical situation.
The local tumour control studies showed that even within the clinically relevant HbCO range the radiation. response was significantly reduced for single-dose and fractionated irradiation with five or ten fractions. Similar or greater radioprotection has been found in the SCCVII tumour using the in vivo excision assay (C. Grau, unpublished observations, 1993 The only schedule in the present set-up where CO breathing did not decrease the radiation response was when 15 fractions were delivered as three daily fractions. A possible explanation of this finding may be that reoxygenation in such a hyperfractionated setting is not complete between fractions, and the contribution of 'CO-induced hypoxia' is therefore less important. There are some data to support this hypothesis. Using the previously published local tumour control data for clamped tumours (Bentzen & Grau, 1991) , it was possible to calculate the 'effective' hypoxic fractions for the different fractionation schedules similar to what was done for the single-dose data. For five fractions (i.e. 24 h interval) the effective hypoxic fraction was significantly lower than that for untreated tumours (1.5% vs 8%), indicating that reoxygenation between fractions was very efficient (Table I and Figure 10 ). The hypoxic fraction was increased by a factor of 2 by CO breathing. For twice-daily fractionation (i.e. 6 and 18 h intervals) the hypoxic fraction was 13% in aerobic tumours, indicating that reoxygenation was almost complete. Again, CO breathing caused a doubling of the hypoxic fraction. For three daily fractions (i.e. 6-6- intervals), however, the effective hypoxic fraction increased to 40%, possibly as a result of insufficient reoxygenation. In this situation CO breathing did not further increase the hypoxic fraction.
The clinical data on the influence of smoking on radiation response are remarkably sparse. A recent prospective study has shown that the survival of smokers undergoing radiotherapy for head and neck cancer is significantly reduced compared with non-smokers of the same clinical stage (Browman et al., 1993) . The 2-year disease-free survival rate was 66% in non-smokers compared with 39% in the patients who continued to smoke during treatment (P = 0.005). The conclusion of the study was that patients should be advised to stop smoking during therapy. Similar suggestions have been made retrospectively in carcinoma of the uterine cervix (Kucera et al., 1987) , but in another study in the same patient category smoking was found to be a non-significant prognostic factor (Solberger & Sorbe, 1990 ).
Protection of the normal tissue by CO breathing may influence the therapeutic importance of the present findings. However, in a recent study (Browman et al., 1993) , no difference in the incidence and severity of stomatitis and skin toxicity between smokers and abstainers was found. Apart from these studies there exist (at least to our knowledge) no good data on this topic.
In conclusion, the present data have shown that elevated HbCO levels can lead to increased tumour hypoxia as a result of changes in blood oxygenation and tumour blood perfusion, and that the induced hypoxia has a significant impact on the local tumour control after both single-dose and fractionated irradiation.
